Transforming activity of AML1-ETO is independent of CBFβ and ETO interaction but requires formation of homo-oligomeric complexes
Open Access
- 24 February 2009
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 106 (8), 2853-2858
- https://doi.org/10.1073/pnas.0810558106
Abstract
Although both heterodimeric subunits of core binding factors (AML1/RUNX1 and CBFβ) essential for normal hematopoiesis are frequently mutated to form different chimeric fusion proteins in acute leukemia, the underlying molecular mechanisms and structural domains required for cellular transformation remain largely unknown. Despite the critical role of CBFβ for wild-type AML1 function and its direct involvement in chromosomal translocation, we demonstrate that both the expression and interaction with CBFβ are superfluous for AML1-ETO (AE)-mediated transformation of primary hematopoietic cells. Similarly, the hetero-oligomeric interaction with transcriptional repressor ETO family proteins and the highly conserved NHR1 domain in AE fusion are also dispensable for transforming activity. In contrast, AE-mediated transformation is critically dependent on the DNA binding and homo-oligomeric properties of the fusion. Abolishment of homo-oligomerization by a small-molecule inhibitor could specifically suppress AML1 fusion-mediated transformation of primary hematopoietic cells. Together, these results not only identify the essential molecular components but also potential avenues for therapeutic targeting of AE-mediated leukemogenesis.Keywords
This publication has 40 references indexed in Scilit:
- Review: genetic models of acute myeloid leukaemiaOncogene, 2008
- Mechanism for ubiquitylation of the leukemia fusion proteins AML1‐ETO and PML‐RARαThe FASEB Journal, 2007
- Tumour prevention by a single antibody domain targeting the interaction of signal transduction proteins with RASThe EMBO Journal, 2007
- The acute myeloid leukemia fusion protein AML1-ETO targets E proteins via a paired amphipathic helix-like TBP-associated factor homology domainProceedings of the National Academy of Sciences of the United States of America, 2006
- Forced homo-oligomerization of RARα leads to transformation of primary hematopoietic cellsCancer Cell, 2006
- Forced retinoic acid receptor α homodimers prime mice for APL-like leukemiaCancer Cell, 2006
- E Protein Silencing by the Leukemogenic AML1-ETO Fusion ProteinScience, 2004
- Origins of chromosome translocations in childhood leukaemiaNature Reviews Cancer, 2003
- A ligand-reversible dimerization system for controlling protein–protein interactionsProceedings of the National Academy of Sciences of the United States of America, 2000
- A simple screening for mutant DNA binding proteins: application to murine transcription factor PEBP2α subunit, a founding member of the Runt domain protein familyGene, 1997